Deisseroth on new step ChR2

Posted by Neville Sanjana at 1:01 PM EST

Nature methods has a small piece interviewing Karl Deisseroth on properties of the new step ChR2.

Some shortcomings of step ChR2 and future research directions:

Deisseroth expects ongoing efforts to improve key features of these channels. “One disadvantage is that some of the mutants have reduced current compared to wild type, so multiple mutations may help to bring those current levels back up to wild-type levels,” he says. Projects designed to improve membrane targeting and to apply a composite of opsins, including the red light–responsive channelrhodopsin from Volvox carteri, are also in the works in his laboratory.

Leave a Reply

 

Additional comments powered by BackType

  • nd categories

  • contact us

    Neurodudes is moderated by Neville Sanjana, Bayle Shanks, and Stephen Larson. Comments that you post might be delayed so that we can tell our software that it's not spam -- however, not all comments are pre-screened so don't assume that we have read them, either. Any money we make off this site is used to pay for hosting, or given to charity; if in the future we pay contributors, we will include reader-authors. None of us are medical doctors so please don't ask for medical advice. Contact us here.